Elango Kalavathy Jayapal, Suresh Amritha, Erode Elango Murugaian, Subhadradevi Lakshmi, Ravindran Hiran Kattilaparambil, Iyer Subramania Kulathu, Iyer Sundaram Karimassery Rama, Kuriakose Moni Abraham
Mazumdar-Shaw Cancer Center, Narayana Hrudayalaya Medical City, Bangalore, India.
Asian Pac J Cancer Prev. 2011;12(4):889-96.
Human papilloma virus (HPV) is an important risk factor for head and neck cancer, specifically oropharyngeal cancer, but its association with oral tongue squamous cell carcinoma (SCC) is uncertain. The objectives were to determine the HPV16 prevalence in oral tongue SCCs, its integration status and to correlate the expression of oncogenic proteins with targets.
In this case-control study with oral tongue SCC cases (n=60) and normal oral mucosa (n=46), HPV positivity was determined by polymerase chain reaction (PCR) using consensus and HPV 16 type specific primers and p16 immunohistochemistry (IHC). The viral integration status was determined with primers specific to the E2 gene and in situ hybridization (ISH). Immunohistochemical analysis of HPV oncogenic proteins (E6, E7) and their target proteins (p53, pRb, cyclinD1, p16, Notch-1, EGFR) proteins was carried out in HPV positive cases. The data was analyzed with SPSS software (v 11.0). Survival analysis was carried out by the Kaplan-Meier method.
HPV16 was detected in 48% (n=29) of the cases and none of the controls by PCR assay (p<0.001) while p16 IHC, as a surrogate HPV marker, detected 33% (n=18) of the cases; 18% (n=10) were detected by both the methods. Integration was observed in 83% (n=24) by E2-PCR and 67% (n=18) by ISH. The E6-p53 pathway was active in 33% of the cases; E7-pRb in 52% and both in 11%. HPV positivity was associated with well-differentiated cancers (p=0.041) and low recurrence rate (p=0.014).
Our study confirms a positive correlation of HPV infection with oral tongue cancer.
人乳头瘤病毒(HPV)是头颈癌尤其是口咽癌的重要危险因素,但其与口腔舌鳞状细胞癌(SCC)的关联尚不确定。目的是确定口腔舌SCC中HPV16的患病率、其整合状态,并将致癌蛋白的表达与靶点相关联。
在这项病例对照研究中,纳入口腔舌SCC病例(n = 60)和正常口腔黏膜(n = 46),采用聚合酶链反应(PCR),使用通用引物和HPV 16型特异性引物以及p16免疫组织化学(IHC)来确定HPV阳性。用E2基因特异性引物和原位杂交(ISH)确定病毒整合状态。对HPV阳性病例进行HPV致癌蛋白(E6、E7)及其靶蛋白(p53、pRb、细胞周期蛋白D1、p16、Notch-1、表皮生长因子受体(EGFR))的免疫组织化学分析。数据用SPSS软件(v 11.0)进行分析。采用Kaplan-Meier法进行生存分析。
通过PCR检测,48%(n = 29)的病例中检测到HPV16,而对照组均未检测到(p < 0.001);作为替代HPV标志物的p16 IHC检测到33%(n = 18)的病例;两种方法均检测到18%(n = 10)的病例。通过E2-PCR观察到83%(n = 24)的病例存在整合,通过ISH观察到67%(n = 18)的病例存在整合。33%的病例中E6-p53途径活跃;52%的病例中E7-pRb途径活跃,11%的病例中两者均活跃。HPV阳性与高分化癌症相关(p = 0.041)且复发率低(p = 0.014)。
我们的研究证实HPV感染与口腔舌癌呈正相关。